The Dose Response of Prednisone on Biochemical and Clinical Makers in Adult Healthy Volunteers

Completed · Phase 1 · Has a placebo group

Conditions studied: Healthy Adults

In brief

The purpose of this study is to further access the utility of biochemical and clinical biomarkers for glucocorticoid-mediated anti-inflammatory effects and safety endpoints against which dissociated agonists of the glucocorticoid receptor (DAGR) will be evaluated in adult healthy volunteers.

Key facts

Study ID

NCT02767089

Run by

Pfizer

People needed

37

Starts

2005-10-01

Expected to finish

2006-03-01

Last updated by the study team

2016-05-10

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy male or females willing to be confined and comply with scheduled visits
• Women are to be surgically sterile.

You may not qualify if…

• History of febrile illness within 5 days prior to the first dose
• Positive urine drug screen
• Treatment with an investigational product within 30 days prior to the first dose of study medication

Where it is running

• Jasper Clinic, Inc. — Kalamazoo, Michigan, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.